Modern bioassays tend to fall under three common modalities: colorimetric, luminometric or fluorometric. Colorimetric assays record the amount of light absorbed by a reporter compound. This absorbance ...

Sometimes, toxic side effects aren't discovered until fairly late in the drug development process, when substantial amounts of time and money have already been invested in clinical trials. Even though ...

The latest advances in genome sequencing indicate proteases occur naturally in all organisms and account for about 2% of the human genome and 1–5% of genomes of infectious organisms. The human genome ...

Truetide said on Wednesday that its wholly-owned subsidiary Paraytec had launched a focused development programme aimed at establishing a high-throughput, real-time fluorescent assay to study ...

Founded in 2001 by Fei Mao and Vivien Chen, Biotium has become a mainstay of high-performance fluorescent reagents for the life sciences. By uniting chemists and biologists, the company continues to ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Mutations in the GNAO1 gene can lead to severe neurological disorders, leading to treatment-resistant epilepsy, developmental delay and movement disorders in children. Zinc supplementation has emerged ...

Adenine and guanine nucleotides are interconverted by diverse proteins of therapeutic interest, including kinases, phosphodiesterases, membrane transporters, DNA-modifying enzymes, and molecular ...